Citizens Business Bank Novo Nordisk A S Transaction History

Citizens Business Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2014 Nov 18, 2022	SELL	N/A	-11,326 Closed	0 $0
Q4 2013 Nov 18, 2022	SELL	N/A	-2,625 Reduced 18.82%	11,326 $2.09 Million
Q3 2013 Nov 18, 2022	SELL	N/A	-3,173 Reduced 18.53%	13,951 $2.36 Million
Q2 2013 Nov 18, 2022	SELL	N/A	-2,123 Reduced 11.03%	17,124 $2.65 Million
Q1 2013 Nov 18, 2022	SELL	N/A	-572 Reduced 2.89%	19,247 $3.11 Million
Q4 2012 Nov 18, 2022	BUY	N/A	19,819	19,819 $3.24 Million

1,879

317M

5.49M

7.77M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $190B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Citizens Business Bank, based on Form 13F filings with the SEC.

Stay updated on Citizens Business Bank with notifications on news.